Product Purity and Quality Standards Peptides supplied for laboratory and in-vitro research use only
By conjugating therapeutic peptides to these bone-targeting sequences, they can achieve higher local concentrations at the exact site where healing is needed while minimizing systemic exposure
So why, then, would we use Methionine (thought to activate mTOR) in our B12/MIC formulation
The table below shows example preparations vial size, an example water volume, and the resulting concentration
Maintenance phase: After noticeable improvement, some protocols suggest reducing to 2-6 mg per month , adjusted according to clinical evaluation
2390 3590 1200 : 2790 BPC-157 (Body Protective Compound 157) 15 , ,